Aura Biosciences is refocusing…
Aura Biosciences is refocusing under its recently installed CEO, laying [...]
Infinimmune has amassed further…
Infinimmune has amassed further fuel to power its antibody discovery [...]
Vaderis Therapeutics has secured…
Vaderis Therapeutics has secured an oversubscribed $152 million series B [...]
AbCellera has reported phase 2…
AbCellera has reported phase 2 results “beyond even the most [...]
Sobi has bought into Innate…
Sobi has bought into Innate Pharma’s vision for lacutamab, handing [...]
Arpeggio Biosciences’ eight-year…
Arpeggio Biosciences’ eight-year song has come to an end as [...]
Boston biotech Ensoma is doubling…
Boston biotech Ensoma is doubling down on its lead gene [...]
Two growing biotechs blasted…
Two growing biotechs blasted through their IPO expectations Friday, with [...]
BioMarin Pharmaceutical has ended…
BioMarin Pharmaceutical has ended development of BMN 401 in all [...]
After a six-month wait, BioNTech…
After a six-month wait, BioNTech has finally filled its vacant [...]